(Q33860266)

29 July 2017

1 reference

title

Endogenous inhibitory mechanisms in asthma (English)

1 reference

29 July 2017

1 reference

Barnes PJ

1

1 reference

PubMed ID

10712370

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

American Journal of Respiratory and Critical Care Medicine

29 July 2017

1 reference

29 July 2017

161

1 reference

29 July 2017

3 Pt 2

1 reference

29 July 2017

S176-81

1 reference

Inhibitory cytokines in asthma

29 July 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Late asthmatic response to Ascaris antigen challenge in dogs treated with metyrapone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Endogenous cortisol regulates immunoglobulin E-dependent late phase reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Lipoxin A4: a novel anti-inflammatory molecule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Adrenomedullin, a newly discovered hypotensive peptide, is a potent bronchodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Production of adrenomedullin in macrophage cell line and peritoneal macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Nitric oxide and airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

21 January 2018

NO or no NO in asthma?

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Dual action of nitric oxide on airway plasma leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5'-monophosphate in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Heme oxygenase: a novel target for the modulation of the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

IL-10: a potential therapy for allergic inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

An investigation of polymorphism in the interleukin-10 gene promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Haplotype associated with low interleukin-10 production in patients with severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Interleukin-12 as a target for modulation of the inflammatory response in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Role of IFN-gamma in the inhibition of the allergic airway inflammation caused by IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Interleukin 13 inhibits macrophage inflammatory protein-1 alpha production from human alveolar macrophages and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Inhibition of inducible nitric oxide synthase expression by interleukin-4 and interleukin-13 in human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Bronchoprotective role for endogenous prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

Effect of Inhaled Prostaglandin E2on Allergen-induced Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-6

10.1164/AJRCCM.161.SUPPLEMENT_2.A1Q4-6

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10712370